StockTipsArenaBeta

BUY Akums Drugs and Pharmaceuticals — Kush Bohra

BUYAkums Drugs and Pharmaceuticals
Akums Drugs and Pharmaceuticals share price target & all analyst calls

byKush BohraHorizon: NA (inferred Swing (≤2wk))19 Aug 2026via NDTV Profit (Live)

Entry₹746Inferred
Target₹795
Total upside +6.57% (call closed)
Stop loss₹725-2.82% risk
Exit₹7951 Sept 2026, 10:10 am
Target hit+6.57%0.00%upside left
Follow Kush Bohra for new calls(32% target hit, 188 closed calls)Get alertsWatch AKUMS for new buy/sell callsGet alertsSee 152 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 1 Sept 2026
8 supporting2 neutral0 opposing
Supports the BUY call (8)

Akums Drugs: Citi hikes target to Rs 860, sees 15% upside on CDMO strength

NewsGoogle News·18 Aug · 2w ago

(opens in new tab)

Akums Drugs Q1FY27 net profit surges 56%; concall flags API turnaround

NewsGoogle News·13 Aug · 3w ago

(opens in new tab)

Earnings Beat: Akums Drugs and Pharmaceuticals Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

NewsGoogle News·12 Aug · 3w ago

(opens in new tab)

Akums Drugs Target Price Hiked to Rs 850 by ICICI Securities

NewsGoogle News·11 Aug · 3w ago

(opens in new tab)

Buy Akums Drugs and Pharmaceuticals; target of Rs 850: ICICI Securities

NewsGoogle News·11 Aug · 3w ago

(opens in new tab)
Neutral / worth noting (2)

Un-audited Financial Results for the Quarter ended 30th June, 2026

BSE · Board Meeting·8 Aug · 3w ago

(opens in new tab)

Akums Drugs and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·8 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Akums Drugs and Pharmaceuticals

All analyst calls on Akums Drugs and Pharmaceuticals

More from Kush Bohra

Every call and its outcome